PTEN and prostate cancer: More importantly, the systemic administration of this TGFβ receptor trap inhibited tumor cell proliferation and the invasion potential of tumor cells in high grade prostatic intraepithelial neoplasia lesions in a prostate-specific knockout mice model of PTEN, one of the most common tumor suppressor genes altered in prostate cancer [104].